Pegmatis to sponsor BVX 2026 health startup pitch prize

Pegmatis will exhibit at the Brampton Venture Expo on Sept. 10, 2026, at the Rose Theatre in Brampton, Ontario, and sponsor the Mitacs Health Innovation Showcase. The company will also award $15,000 in product development work to the winning healthcare startup, aiming to help early-stage teams move faster toward commercialization.

Why it matters: - Pegmatis is using BVX 2026 to reach startups, investors and ecosystem leaders working on healthtech and other complex products. - The sponsorship ties technical development support directly to an early-stage pitch competition, which can help a healthcare startup reduce product risk and advance toward market readiness.

What happened: - Pegmatis announced it will exhibit at the Brampton Venture Expo on Sept. 10, 2026, at the Rose Theatre in Brampton, Ontario. - The hardware, software and firmware product development firm will also sponsor the Mitacs Health Innovation Showcase. - Pegmatis will be stationed in the main lobby at the venue entrance throughout the event. - The company will present a major prize during the flagship pitch competition.

The details: - The Mitacs Health Innovation Showcase will feature the top five startups from the Brampton Venture Zone cohort. - The startups will pitch to a panel of judges and the BVX audience. - The participating startups are competing for up to $70,000 in total prize funding. - Pegmatis will award the winner $15,000 worth of product development work. - The prize is meant to help an emerging healthcare startup accelerate its product roadmap, clear hardware or software bottlenecks and move closer to commercialization. - Pegmatis will have leadership available to meet founders, investors and industry executives at the Main Lobby during the event. - More information is available at Pegmatis and the Brampton Venture Expo schedule.

Between the lines: - Pegmatis is positioning itself as more than a vendor by linking its engineering expertise to a visible startup prize. - The focus on regulated healthtech suggests the company sees demand for specialized product development support in sectors where technical execution can affect fundraising and commercialization. - Ed Becze, managing partner and CEO at Pegmatis, said early-stage product development in healthtech requires technical precision and deep experience. - Becze said the prize gives the winning startup dedicated engineering support that can help de-risk technology and build investor confidence.

What's next: - BVX 2026 and the Mitacs Health Innovation Showcase will take place on Sept. 10, 2026. - Attendees can meet the Pegmatis leadership team during the event. - The pitch competition will determine which healthcare startup receives the $15,000 development prize.

The bottom line: - Pegmatis is turning its BVX presence into a direct bet on regional healthtech startups, with money, engineering support and visibility tied to the event's top pitch prize.